News
Medigen Presents GMP manufacturing of Lassa and VEEV vaccines
At the 2026 MCDC Annual Meeting, Medigen scientists highlighted advanced progress on Lassa and VEEV virus vaccines, addressing a critical need for approved treatments against these […]
Medigen presents vaccine research at ASV 2024
Medigen and the University of Louisville (UofL) present collaborative research on V5040 chikungunya vaccine at the Annual meeting of the […]
VACCINE COMPANY MEDIGEN DOUBLES PRESENCE IN RIVERSIDE TECHNOLOGY PARK TO 12,000 SQUARE FEET OF SPACE WITH PLANS TO INCREASE VACCINE MANUFACTURING
Company engaged in contract manufacturing and developing vaccines against infectious diseases expanding at Gas House Pike to support additional office, research and manufacturing space
Medigen reports vaccines for Venezuelan Equine Encephalitis and Chikungunya viruses
January 29, 2019. Medigen presented experimental vaccines for two life-threatening emerging viruses at the 2019 ASM Biothreats conference in Washington, DC. Venezuelan […]